$5.32
Today
as of Sep 4, 16:54 ET
Last 30 days
Recent Press Releases & News
Strata Critical Medical, Inc. (SRTA) Upgraded to Buy: What Does It Mean for the Stock?
Does Strata Critical Medical, Inc. (SRTA) Have the Potential to Rally 47.28% as Wall Street Analysts Expect?
Strata Critical Medical (SRTA) Q2 2026 Earnings Call Transcript
Overview
52-week range
$3.85
$6.50
55% of range
Avg surprise (last 3)
+71.2%
Avg reaction (last 2)
+14.5%
100% positive
Latest IV / EM
114%
EM ±17.9% · $5 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.12 | — | — | — | — | financials |
| Wed May 6, 2026 | Mar/2026 | $0.03 | $-0.04 | +175.0% | +175.0% | +10.6% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.70 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $-0.05 | $-0.04 | -25.0% | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-0.04 | $-0.11 | +63.6% | — | +18.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.03 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.15 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.06 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | — | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.17 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.14 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $73M | $67M | — | $49M | $45M | $36M | — | $36M |
| Cost of revenue | $57M | $53M | — | $38M | $36M | $29M | — | $29M |
| Gross profit | $15M | $14M | — | — | $9M | $7M | — | — |
| Operating income | $-5M | $-3M | — | $-6M | $-5M | $-6M | — | $-7M |
| Net income | $-11M | $2M | — | $57M | $-4M | $-3M | — | $-2M |
| EPS (diluted) | $-0.12 | $0.03 | — | $0.70 | $-0.05 | $-0.04 | — | $-0.03 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $16M | $59M | — | $23M | $59M | $35M | $16M | $20M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $121M | $124M | $126M | $122M | $156M | $152M | $161M | $172M |
| Total assets | $333M | $328M | $325M | $335M | $258M | $251M | $257M | $283M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $53M | $42M | $46M | $52M | $35M | $31M | $35M | $49M |
| Total equity | $279M | $286M | $279M | $283M | $223M | $220M | $222M | $233M |